Bank Of New York Mellon Corp Hookipa Pharma Inc. Transaction History

Bank Of New York Mellon Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.33 - $2.31 $81,059 - $140,787	-60,947 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$1.26 - $2.52 $788 - $1,577	-626 Reduced 1.02%	60,947 $139,000
Q4 2021 Feb 11, 2022	SELL	$2.33 - $5.94 $2,055 - $5,239	-882 Reduced 1.41%	61,573 $144,000
Q3 2021 Nov 12, 2021	BUY	$5.89 - $9.35 $22,664 - $35,978	3,848 Added 6.57%	62,455 $368,000
Q2 2021 Aug 11, 2021	BUY	$9.16 - $19.51 $168,021 - $357,871	18,343 Added 45.56%	58,607 $536,000
Q1 2021 May 13, 2021	SELL	$10.64 - $14.7 $5,586 - $7,717	-525 Reduced 1.29%	40,264 $541,000
Q4 2020 Feb 09, 2021	BUY	$9.32 - $13.63 $66,582 - $97,372	7,144 Added 21.23%	40,789 $452,000
Q3 2020 Nov 12, 2020	BUY	$8.59 - $11.89 $6,399 - $8,858	745 Added 2.26%	33,645 $318,000
Q2 2020 Aug 12, 2020	SELL	$7.23 - $12.1 $10,736 - $17,968	-1,485 Reduced 4.32%	32,900 $382,000
Q1 2020 May 06, 2020	BUY	$5.9 - $13.8 $36,538 - $85,463	6,193 Added 21.97%	34,385 $283,000
Q4 2019 Feb 14, 2020	BUY	$6.51 - $12.23 $97,513 - $183,193	14,979 Added 113.37%	28,192 $344,000
Q3 2019 Nov 07, 2019	BUY	$6.45 - $8.44 $85,223 - $111,517	13,213 New	13,213 $99,000

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $98.7M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.